We are live on ! Find out more
AGIO icon

Agios Pharmaceuticals
AGIO

72 hedge funds and large institutions have $242M invested in Agios Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 72 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
+72
Holders Change %
–
% of All Funds
2.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
72
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$61.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$30.3M
3
Franklin Resources
Franklin Resources
California
+$17.4M
4
BCPEM
Bain Capital Public Equity Management
Massachusetts
+$14.4M
5
Morgan Stanley
Morgan Stanley
New York
+$7.81M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$62.4M +$61.6M +2,231,565 New
Wellington Management Group
2
Wellington Management Group
Massachusetts
$30.7M +$30.3M +1,096,288 New
Franklin Resources
3
Franklin Resources
California
$17.6M +$17.4M +629,400 New
BCPEM
4
Bain Capital Public Equity Management
Massachusetts
$14.6M +$14.4M +521,800 New
Morgan Stanley
5
Morgan Stanley
New York
$7.91M +$7.81M +282,907 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$7.57M +$7.47M +270,709 New
Federated Hermes
7
Federated Hermes
Pennsylvania
$7.55M +$7.45M +270,000 New
DCM
8
Driehaus Capital Management
Illinois
$7.21M +$7.12M +257,971 New
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$6.09M +$6.02M +218,000 New
PHS
10
PFM Health Sciences
California
$5.78M +$5.71M +206,829 New
BBA
11
Baker Bros. Advisors
New York
$5.59M +$5.52M +200,000 New
BI
12
BVF Inc
California
$5.51M +$5.44M +196,996 New
BFA
13
BlackRock Fund Advisors
California
$4.91M +$4.85M +175,610 New
ClearBridge Investments
14
ClearBridge Investments
New York
$4.9M +$4.84M +175,220 New
Jennison Associates
15
Jennison Associates
New York
$4.89M +$4.83M +175,000 New
DM
16
Deerfield Management
New York
$4.22M +$4.17M +151,050 New
KCM
17
Kornitzer Capital Management
Kansas
$3.05M +$3.01M +109,200 New
BA
18
BlackRock Advisors
Delaware
$2.56M +$2.53M +91,596 New
BIT
19
BlackRock Institutional Trust
California
$2.34M +$2.31M +83,722 New
WMSA
20
Weiss Multi-Strategy Advisers
New York
$2.25M +$2.22M +80,500 New
TI
21
Turner Investments
Pennsylvania
$2.07M +$2.05M +74,210 New
TG
22
TCW Group
California
$1.98M +$1.96M +70,956 New
AG
23
Artal Group
Luxembourg
$1.96M +$1.93M +70,000 New
Capital World Investors
24
Capital World Investors
California
$1.96M +$1.93M +70,000 New
RCM
25
RA Capital Management
Massachusetts
$1.96M +$1.93M +70,000 New
1
2 3

AGIO Hedge Fund Activity: Q3 2013 in Review

72 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Agios Pharmaceuticals (AGIO) for Q3 2013, worth a combined $242M.

Buyers outnumbered sellers: 72 funds opened new AGIO positions and 0 closed out — a net gain of 72 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $61.6M.

  • 72 institutional investors held Agios Pharmaceuticals (AGIO) as of Q3 2013, up from 0 in Q2 2013.
  • Funds reported $242M of Agios Pharmaceuticals stock for Q3 2013.
  • 72 funds opened new Agios Pharmaceuticals positions in Q3 2013 and 0 closed out, a net change of +72 holders.
  • The largest Agios Pharmaceuticals buyer in Q3 2013 was Fidelity Investments, an estimated $61.6M added.

Based on aggregated 13F filings for Q3 2013.